Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

06.07.16	Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer (Businesswire)
28.06.16	Pfizer Says SPIRE-HR And SPIRE-FH Trials Meet Primary Endpoints (RTTNews)
28.06.16	Pfizer To Invest About $350 Mln In Global Biotechnology Center In China (RTTNews)
24.06.16	Pfizer Completes Acquisition Of Anacor Pharma (RTTNews)
15.06.16	CHMA Trims Workforce, INFI's DYNAMO Disappoints, Marathon Joins DMD Race (RTTNews)
14.06.16	Shire To License IBD Drug PF-00547659 From Pfizer; Terms Not Disclosed (RTTNews)
10.06.16	ICON Signs 3-year Deal With Pfizer; Terms Not Disclosed - Quick Facts (RTTNews)
10.06.16	PAREXEL To Continue To Provide Research, Development Services To Pfizer (RTTNews)
09.06.16	FDA Panel Nod For PFE, INSM Withdraws MAA, FCSC's Voice Fades Out (RTTNews)
09.06.16	Pfizer : FDA Panel Recommends ALO-02 Extended-Release Capsules For Approval (RTTNews)
07.06.16	Pfizer Announces Positive Results From Second Phase 3 Trial Of Oral XELJANZ (RTTNews)
06.06.16	Pfizer Says Pivotal Avelumab Study Shows Positive Results In MCC (RTTNews)
06.06.16	ASCO 2016: Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel Cell Carcinoma (Businesswire)
06.06.16	Pfizer Announces New Data From Phase 1/2 Study Of Lorlatinib (RTTNews)
04.06.16	Pfizer Reports Encouraging Safety Data For Novel Immunotherapy Combinations (RTTNews)
31.05.16	BioRap Tech Collaborates With Pfizer To Research &Develop Novel Immunomodulators (RTTNews)
29.05.16	Biotech Stocks Facing FDA Decision In June (RTTNews)
23.05.16	Pfizer Reports Label Update For CHAMPIX In European Union - Quick Facts (RTTNews)
23.05.16	CHAMPIX® (varenicline) European Union Label Updated to Include New Safety and Efficacy Data from the EAGLES Clinical Trial Following Endorsement from CHMP (Businesswire)
20.05.16	Pfizer: EMA Accepts Trumenba's Marketing Authorization Application For Review (RTTNews)
20.05.16	Pfizer Announces European Medicines Agency Acceptance for Review of Marketing Authorization Application for TRUMENBA® (Meningococcal Group B Vaccine) (Businesswire)
19.05.16	Spark, Pfizer Announce Data From Initial Subjects In Hemophilia B Trial (RTTNews)
19.05.16	Merck KGaA, Pfizer To Present Avelumab Data In Seven Different Cancers At ASCO (RTTNews)
18.05.16	Merck and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting (Businesswire)
16.05.16	Anacor Jumps On Takeover By Pfizer (RTTNews)
16.05.16	Pfizer To Acquire Crisaborole Developer Anacor Pharma In $5.2 Bln Deal (RTTNews)
16.05.16	Pfizer To Buy Crisaborole Developer Anacor Pharma For $5.2 Bln - Quick Facts (RTTNews)
05.05.16	WAVE Life Sciences Enters Into Research, License And Option Deal With Pfizer (RTTNews)
03.05.16	Pfizer Q1 Results Top Estimates, Raises 2016 Outlook; Stock Up (RTTNews)
03.05.16	Pfizer Inc. Q1 Profit Climbs 30% (RTTNews)
28.04.16	Pfizer Agrees To Pay $784.6 Mln To Settle Drug Discount Case (RTTNews)
27.04.16	BEAT Upbeat, COLL Gets Final FDA Nod, CPRX Crushed (RTTNews)
26.04.16	Pfizer Announces Patient Enrollment Completion In SPIRE-2 Cardiovascular Trial (RTTNews)
20.04.16	MOH Opens Wallet, PFE's Ibrance A Step Closer To Full Approval, SGYP To Face FDA (RTTNews)
19.04.16	Pfizer Reports Positive Top-Line Results For Phase 3 PALOMA-2 Trial Of IBRANCE (RTTNews)
16.04.16	NY Attorney General Sues CDPHP For Unlawfully Denying Coverage Of HCV Treatment (RTTNews)
07.04.16	Pfizer, IBM In Research Collaboration To Transform Parkinson's Disease Care (RTTNews)
07.04.16	Shire Says Proposed Merger With Baxalta On Track To Close In Mid-2016 (RTTNews)
07.04.16	BIND In A Fix, APRI To File NDA In Q3, TSRO Abuzz (RTTNews)
06.04.16	Pfizer Terminates $160 Bln Merger Deal With Allergan (RTTNews)
06.04.16	Pfizer, Allergan Terminate Merger (RTTNews)
06.04.16	The U.S. Gets 2nd Biosimilar, ORMP Awaits Data This Qtr, PFE Hits Mark In OPAL (RTTNews)
06.04.16	Pfizer Reportedly Decides To Terminate Merger With Allergan (RTTNews)
05.04.16	Merck, Pfizer Begins Phase III Combination Trial For Advanced Renal Cell Cancer (RTTNews)
05.04.16	Merck KGaA, Pfizer: First Patient Treated In Phase III Study Of Avelumab, Inlyta (RTTNews)
05.04.16	Merck KGaA, Darmstadt, Germany, and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinoma (Businesswire)
05.04.16	Merck and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinoma (Businesswire)
05.04.16	Pfizer Says OPAL Broaden Phase 3 Study Meets Primary Efficacy Endpoints (RTTNews)
05.04.16	Allergan Plunges On U.S. Tax Inversion Move (RTTNews)
01.04.16	Pfizer Announces Positive Results From Second Phase 3 Lipid-Lowering Study (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

13:32		Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen
27.12.24		Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus
27.12.24		BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester
27.12.24		Dow Jones aktuell: Dow Jones verliert am Freitagnachmittag
27.12.24		Schwacher Wochentag in New York: Dow Jones verbucht am Freitagmittag Verluste
27.12.24		Börse London in Grün: FTSE 100 zum Ende des Freitagshandels freundlich
27.12.24		Optimismus in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
27.12.24		Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge

13:32

Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen

27.12.24

Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus

27.12.24

BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester

27.12.24

Dow Jones aktuell: Dow Jones verliert am Freitagnachmittag

27.12.24

Schwacher Wochentag in New York: Dow Jones verbucht am Freitagmittag Verluste

27.12.24

Börse London in Grün: FTSE 100 zum Ende des Freitagshandels freundlich

27.12.24

Optimismus in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

27.12.24

Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Pfizer Inc.

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten